PPT-Tracking recurrence In population-based cancer surveillance

Where to start Literally Loria Pollack MD MPH Senior Medical Officer Epidemiologist CDC National Programs of Cancer Registries NAACCR 2019 Vancouver June 13 2019 Tracking Recurrence. Partial . Breast Irradiation: . The Evolution of Breast Cancer Care. Johnny Ray Bernard, Jr., M.D.. October 19, 2012. 1852: Born in New York City Sept. 23. 1870: Graduates from Phillips Academy Andover. Recurrence after Rayour prostate. While the beam is focuRecurrence with Hormone Therapy Hormone therapy shrinks prostate cancer and kills many, but not all prostate cancer. Hormone therapy lowers t March 2011. session. Definition. Conditions. Types. Methods. Recommendations. Definition. An ongoing systematic collection, analysis, interpretation, and dissemination of health . data. An ongoing exercise of . Breast Cancer Recurrence. anytime, mostly occur in the first 3 – 5 years after initial treatment. can come back as a local recurrence (in the treated breast or near the mastectomy scar) or as a distant recurrence somewhere else in the body . for . Image-Guided . Interventions. Ziv. . Yaniv. Sheikh . Zayed. Institute for Pediatric Surgical Innovation . Children's National Medical Center . Last updated: Sep. 17 2012. Tracking. Continuously determine . Department for the Prevention of NCDs. Implementing the Global Monitoring Framework at country level . . “If you can’t measure, you can’t manage”. Small number of “tracer” targets within a broader framework and set of indicators. Pamela L. Pentin, JD, MD, FAAFP. University of Washington Family Medicine Residency. General Principles. Surveillance for recurrence of primary cancer. Screening for development of a second primary malignancy. to Community . Medicine Course. . . . (31505201. ). . . . Unit 4. Epidemiology. . . Introduction to Epidemiology. Sources of Data and methods of data . collection. Epidemiological Surveillance. after Stopping Endocrine Therapy at 5 . Years. The . Early Breast Cancer . Trialists. ’ Collaborative Group (EBCTCG. ). N . Engl. J Med 2017. ; 377:1836-46. ER+, 5 years. endocrine. therapy (ET). completed:. Research & . Innovation to Support Health Systems. Soumya Swaminathan, MD. DG, Indian . Council of Medical . Research, and Secretary, . Dept. of Health Research, MOH. ICMR Strategic . Plan. Better Health through . Scott D. Hamling, MD,. FACS. The Iowa Clinic Surgical Breast Clinic. JSCC Breast Program Leadership Committee Chair. Contralateral Breast Cancer. . Overview. Review. contralateral breast cancer statistics. Risk factors. Incidence. Survival. Mortality. Population Surveys. PBCRs. PBCRs. Vital statistics. By Cancer Type. By stage. Attributable Risk. Prevalence. DALYs. Associated Economic Costs. Cancer Control Measures. How are cancer statistics kept up to date?. Cancer Reporting. Example: . Dx. stage . II colon . cancer - . 2007 . Cancer has . metastasized to the . liver – 2009. H. ow . does the hospital and clinician . Screening With Risk-Based and Universal Mammography . Screening . Compared With Clinical . Breast . Examination. A Propensity Score Analysis of 1,429,890 Taiwanese Women. 2017 . JAMAOncology. Conclusions.